专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2008119772A1 AMIDE DERIVATIVES AS INHIBITORS OF ASPARTYL PROTEASES 审中-公开
标题翻译：作为ASPARTYL蛋白抑制剂的酰胺衍生物
公开(公告)号：WO2008119772A1
公开(公告)日：2008-10-09
申请号：PCT/EP2008/053765
申请日：2008-03-28
申请人： MEDIVIR AB , KVARNSTRÖM, Ingemar , WÅNGSELL, Fredrik , ROSENQUIST, Åsa , SAMUELSSON, Bertil , SAHLBERG, Christer , SUND, Christian , BELDA, Oscar , IVANOV, Vladimir , ODEN, Lourdes , NORÉN, Rolf
发明人： KVARNSTRÖM, Ingemar , WÅNGSELL, Fredrik , ROSENQUIST, Åsa , SAMUELSSON, Bertil , SAHLBERG, Christer , SUND, Christian , BELDA, Oscar , IVANOV, Vladimir , ODEN, Lourdes , NORÉN, Rolf
IPC分类号： C07C311/08 , A61K31/18 , A61P9/12 , A61P9/04 , A61P27/06 , A61P13/12 , C07C309/66 , C07C311/07 , C07C255/57
CPC分类号： C07C311/08 , C07C255/57 , C07C309/66 , C07C311/07 , C07C2601/02 , C07C2601/08
摘要： The invention provides compounds of the formula (I). N-oxides, addition salts, quaternary amines, metal complexes, stereochemically isomeric forms and metabolites thereof, wherein W is H, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, aryl or heterocyclyl; Q is aryl or heterocyclyl; A is a five or six membered saturated, partially unsaturated or aromatic ring; D is formula (II) or formula (III); and the other variables are as defined in the specification. The compounds of the invention are inhibitors of aspartyl proteases such as renin and BACE and are among other things useful for the treatment and/or prophylaxis of conditions associated with activities of the RAS, such as hypertension, heart failure and renal insufficiency and for the treatment and or prophylaxis of conditions associated with BACE activity such as of Alzheimer's disease.
摘要翻译：本发明提供式（I）化合物。 N-氧化物，加成盐，季胺，金属配合物，立体化学异构形式及其代谢物，其中W是H，C 1 -C 6烷基，C 1 -C 6烷基， 3个-C 6环烷基，芳基或杂环基; Q是芳基或杂环基; A是五或六元饱和，部分不饱和或芳环; D是式（II）或式（III）; 其他变量如规范中所定义。本发明的化合物是天冬氨酰蛋白酶如肾素和BACE的抑制剂，并且用于治疗和/或预防与RAS活性有关的病症，例如高血压，心力衰竭和肾功能不全以及治疗和/或预防与诸如阿尔茨海默氏病之类的BACE活性相关的病症。

2. 发明申请

WO2008107365A1 NEW COMPOUNDS 审中-公开
标题翻译：新化合物
公开(公告)号：WO2008107365A1
公开(公告)日：2008-09-12
申请号：PCT/EP2008/052416
申请日：2008-02-28
申请人： MEDIVIR AB , BELDA, Oscar , SUND, Christian , IVANOV, Vladimir , WIKTELIUS, Daniel , SAHLBERG, Christer , SAMUELSSON, Bertil , ROSENQUIST, Åsa , WÅNGSELL, Fredrik , KVARNSTRÖM, Ingemar
发明人： BELDA, Oscar , SUND, Christian , IVANOV, Vladimir , WIKTELIUS, Daniel , SAHLBERG, Christer , SAMUELSSON, Bertil , ROSENQUIST, Åsa , WÅNGSELL, Fredrik , KVARNSTRÖM, Ingemar
IPC分类号： A61K31/44 , C07D213/40 , C07C237/12 , C07D213/38
CPC分类号： C07D307/33 , C07C237/22 , C07C255/60 , C07D213/38 , C07D213/40
摘要： The invention provides compounds of the formula I wherein Q is aryl or heterocyclyl any of which is optionally substituted; Z is O, S, NRa or S(=O) p ; Y is NH, NHNH, CH 2 NH, O, S or S(=O) p ; n is 0, 1, 2 or 3; m is 0, 1 or 2; p is 1 or 2; Ra is H or C 1 -C 4 alkyl; R 1 is hydrogen, C 1 -C 6 alkyl, C 0 -C 3 alkanediylC 3 -C 7 cycloalkyl, C 0 -C 3 alkanediylaryl or C 0 - C3alkanediylheterocyclyl; R 2 is hydrogen or C 1 -C 6 alkyl; X' is hydrogen, fluoro, hydroxy, amino or C 1 -C 6 alkoxy; X" is hydrogen, or when X' is fluoro, then X" may also be fluoro; R 3 is C 1 -C 6 alkyl; R 4' is C 1 -C 6 alkyl; R 4" is H or C 1 -C 6 alkyl; or R 4' and R 4" together with the carbon atom to which they are attached define a C 3 -C 6 cycloalkyl; W is C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, aryl or heterocyclyl any of which is optionally substituted; or a pharmaceutically acceptable salt, hydrate or N-oxide thereof. The compounds of the invention are inhibitors of aspartyl proteases such as renin and are among other things useful for the treatment of conditions associated with activities of the RAS, such as hypertension, heart failure and renal insufficiency.
摘要翻译：本发明提供式I化合物，其中Q是任选被取代的芳基或杂环基; Z是O，S，NR a或S（= O）p。 Y是NH，NHNH，CH 2 NH，O，S或S（= O）p; n为0,1,2或3; m为0,1或2; p为1或2; R a是H或C 1 -C 4烷基; R 1是氢，C 1 -C 6烷基，C 0 -C 3 - 烷二基C 3 -C 7环烷基，C 0 -C 3烷二基芳基或C 0 < / C3-烷二基杂环基; R 2是氢或C 1 -C 6烷基; R 2是氢或C 1 -C 6烷基; X'是氢，氟，羟基，氨基或C 1 -C 6烷氧基; X“是氢，或者当X'是氟时，X”也可以是氟; R 3是C 1 -C 6烷基; R 3是C 1 -C 6烷基; R 4是C 1 -C 6烷基; R 4是C 1 -C 6烷基; R 4是H或C 1 -C 6烷基;或R 4'和R“ 4“与它们所连接的碳原子一起定义为C 3 -C 6环烷基; W是C 1 -C 6烷基，C 3 -C 7环烷基，芳基或杂环基，其中任何一个任选地被取代; 或其药学上可接受的盐，水合物或N-氧化物。本发明的化合物是天冬氨酰蛋白酶如肾素的抑制剂，并且其它可用于治疗与RAS活性有关的病症，例如高血压，心力衰竭和肾功能不全。

3. 发明申请

WO2008114054A1 PROTEASE INHIBITORS 审中-公开
标题翻译： PROTEASE抑制剂
公开(公告)号：WO2008114054A1
公开(公告)日：2008-09-25
申请号：PCT/GB2008/050193
申请日：2008-03-18
申请人： MEDIVIR AB , KANGASMETSA, Jussi , PARKES, Kevin , TOZER, Matt , JOHNSON, Tony , GRABOWSKA, Urszula , ODEN, Lourdes , SUND, Christian , NILSSON, Magnus , IVANOV, Vladimir , KAHNBERG, Pia
发明人： KANGASMETSA, Jussi , PARKES, Kevin , TOZER, Matt , JOHNSON, Tony , GRABOWSKA, Urszula , ODEN, Lourdes , SUND, Christian , NILSSON, Magnus , IVANOV, Vladimir , KAHNBERG, Pia
IPC分类号： C07D491/04 , A61K31/407 , A61P19/00
CPC分类号： C07D491/04
摘要： Compounds of the formula (II): wherein R 2 is the side chain of leucine, isoleucine, cyclohexylglycine, O-methyl threonine, 4-fluoroleucine or 3-methoxyvaline; R 3 is H, methyl or fluoro; R 4 is C 1 -C 6 alkyl; E is a bond or thiazolyl, optionally substituted with methyl or fluoro; n is 0 or 1; or a pharmaceutically acceptable salt, N-oxide or hydrate thereof; have utility in the treatment of disorders characterized by inappropriate expression or activation of cathepsinK, such as osteoporosis, osteoarthritis, rheumatoid arthritis or bone metastases.
摘要翻译：式（II）的化合物：其中R 2是亮氨酸的侧链，异亮氨酸，环己基甘氨酸，O-甲基苏氨酸，4-氟代亮氨酸或3-甲氧基缬氨酸; R 3是H，甲基或氟; R 4是C 1 -C 6烷基; R 4是C 1 -C 6烷基; E是任选被甲基或氟取代的键或噻唑基; n为0或1; 或其药学上可接受的盐，N-氧化物或其水合物; 可用于治疗特征为组织蛋白酶K不适当表达或活化的疾病，例如骨质疏松症，骨关节炎，类风湿性关节炎或骨转移。

4. 发明申请

WO2007014926A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS 审中-公开
标题翻译： HEPATITIS C病毒的大环境抑制剂
公开(公告)号：WO2007014926A1
公开(公告)日：2007-02-08
申请号：PCT/EP2006/064820
申请日：2006-07-28
申请人： TIBOTEC PHARMACEUTICALS LTD. , MEDIVIR AB , RABOISSON, Pierre Jean-Marie Bernard , DE KOCK, Herman Augustinus , HU, Lili , VENDEVILLE, Sandrine Marie Helene , TAHRI, Abdellah , SURLERAUX, Dominique Louis Nestor Ghislain , SIMMEN, Kenneth Alan , NILSSON, Karl Magnus , SAMUELSSON, Bengt Bertil , ROSENQUIST, Åsa Annica Kristina , IVANOV, Vladimir , PELCMAN, Michael , BELFRAGE, Anna Karin Gertrud Linnea , JOHANSSON, Per-Ola Mikael
发明人： RABOISSON, Pierre Jean-Marie Bernard , DE KOCK, Herman Augustinus , HU, Lili , VENDEVILLE, Sandrine Marie Helene , TAHRI, Abdellah , SURLERAUX, Dominique Louis Nestor Ghislain , SIMMEN, Kenneth Alan , NILSSON, Karl Magnus , SAMUELSSON, Bengt Bertil , ROSENQUIST, Åsa Annica Kristina , IVANOV, Vladimir , PELCMAN, Michael , BELFRAGE, Anna Karin Gertrud Linnea , JOHANSSON, Per-Ola Mikael
IPC分类号： C07D487/04 , C07D245/04 , C07K5/078 , A61K38/05 , A61K31/33 , A61P31/14 , C07K5/06
CPC分类号： C07D487/04 , A61K31/427 , A61K31/4709 , A61K31/7056 , A61K38/05 , A61K38/212 , A61K45/06 , A61K47/60 , C07D245/04 , C07D277/56 , C07D401/14 , C07D417/04 , C07D417/14 , C07K5/06139 , Y02A50/385 , Y02A50/387 , Y02A50/389 , Y02A50/393
摘要： Inhibitors of HCV replication of formula (I) and the N -oxides, salts, and stereoisomers, wherein each dashed line represents an optional double bond; X is N, CH and where X bears a double bond it is C; R 1 is -OR 7 , -NH-SO 2 R 8 ; R 2 is hydrogen, and where X is C or CH, R 2 may also be C 1-6 alkyl; R 3 is hydrogen, C 1-6 alkyl, C 1-6 alkoxyC 1-6 alkyl, C 3-7 cycloalkyl; R 4 is aryl or Het; n is 3, 4, 5, or 6; R 5 is halo, C 1-6 alkyl, hydroxy, C 1-6 alkoxy, phenyl, or Het; R 6 is C 1-6 alkoxy, or dimethylamino; R 7 is hydrogen; aryl; Het; C 3-7 cycloalkyl optionally substituted with C 1-6 alkyl; or C 1-6 alkyl optionally substituted with C 3-7 cycloalkyl, aryl or with Het; R 8 is aryl; Het; C 3-7 cycloalkyl optionally substituted with C 1-6 alkyl; or C 1-6 alkyl optionally substituted with C 3-7 cycloalkyl, aryl or with Het; aryl is phenyl optionally substituted with one, two or three substituents; Het is a 5 or 6 membered saturated, partially unsaturated or completely unsaturated heterocyclic ring containing 1 to 4 heteroatoms selected from nitrogen, oxygen and sulfur, and being optionally substituted with one, two or three substituents ; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I). Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.
摘要翻译：式（I）的HCV复制抑制剂和N-氧化物，盐和立体异构体，其中每个虚线表示任选的双键; X为N，CH，X为双键，C为C; R 1是-OR 7，-NH-SO 2 R 8; R 2是氢，并且其中X是C或CH，R 2也可以是C 1-6烷基; R 3是氢，C 1-6烷基，C 1-6烷氧基C 1-6烷基，C _{3-7 环烷基; R 4是芳基或Het; n为3,4,5或6; R 5为卤素，C 1-6烷基，羟基，C 1-6烷氧基，苯基或Het; R 6是C 1-6烷氧基或二甲基氨基; R 7是氢; 芳基; HET; 任选被C 1-6烷基取代的C 3-7环烷基; 或任选被C 3-7环烷基，芳基或与Het取代的C 1-6烷基; R 8是芳基; HET; 任选被C 1-6烷基取代的C 3-7环烷基; 或任选被C 3-7环烷基，芳基或与Het取代的C 1-6烷基; 芳基是任选被一个，两个或三个取代基取代的苯基; Het是含有1至4个选自氮，氧和硫的杂原子并且任选地被一个，两个或三个取代基取代的5或6元饱和，部分不饱和或完全不饱和的杂环。含有化合物（I）的药物组合物和制备化合物（I）的方法。还提供了式（I）的HCV抑制剂与利托那韦的生物可利用组合。}

5. 发明申请

WO2010034789A1 PROTEASE INHIBITORS 审中-公开
标题翻译： PROTEASE抑制剂
公开(公告)号：WO2010034789A1
公开(公告)日：2010-04-01
申请号：PCT/EP2009/062407
申请日：2009-09-24
申请人： Medivir AB , IVANOV, Vladimir , SAMUELSSON, Bertil , JOHANSSON, Per-Ola , KAHNBERG, Pia , WÄHLING, Horst
发明人： IVANOV, Vladimir , SAMUELSSON, Bertil , JOHANSSON, Per-Ola , KAHNBERG, Pia , WÄHLING, Horst
IPC分类号： C07D491/048 , A61K31/496 , A61P19/00
CPC分类号： C07D491/048
摘要： Compounds of the formula II, wherein R 3 is C 1 -C 3 alkyl or C 3 -C 6 cycloalkyl, either of which is optionally substituted with one or two methyl and/or a fluoro, trifluoromethyl or methoxy, when R 3 is C 3 -C 6 cycloalkyl it may alternatively be gem substituted with fluoro; R 4 is methyl or fluoro; m is 0, 1 or 2; E is a bond, or thiazolyl, optionally substituted with methyl or fluoro; A 1 is CH or N, A 2 is CR 6 R 7 or NR 6 , provided at least one of A 1 and A 2 comprises N; n is 0 or 1 such that the ring containing A 1 and A 2 is a saturated, nitrogen-containing ring of 5 or 6 ring atoms; R 6 is H, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 3 alkyl-O-C 1 -C 3 alkyl, or when A 2 is C, R 6 can also be C 1 -C 4 alkoxy or F; R 7 is H, C 1 -C 4 alkyl or F; or a pharmaceutically acceptable salt, N-oxide or hydrate thereof, have utility in the treatment of disorders characterized by inappropriate expression or activation of cathepsin K, such as osteoporosis, osteoarthritis, rheumatoid arthritis or bone metastases.
摘要翻译：其中R 3为C 1 -C 3烷基或C 3 -C 6环烷基，其中R 3为C 3 -C 6环烷基时，任选被一个或两个甲基和/或氟，三氟甲基或甲氧基取代，被氟取代; R4是甲基或氟; m为0,1或2; E是任选被甲基或氟取代的键或噻唑基; A1是CH或N，A2是CR6R7或NR6，条件是A1和A2中的至少一个包括N; n为0或1，使得含有A 1和A 2的环是5或6个环原子的饱和的含氮环; R6是H，C1-C4烷基，C1-C4卤代烷基，C1-C3烷基-O-C1-C3烷基，或当A2是C时，R6也可以是C1-C4烷氧基或F; R 7为H，C 1 -C 4烷基或F; 或其药学上可接受的盐，N-氧化物或其水合物，可用于治疗组织蛋白酶K不适当表达或活化的疾病，例如骨质疏松症，骨关节炎，类风湿性关节炎或骨转移。

6. 发明申请

WO2013029906A1 RADIATION SOURCE 审中-公开
标题翻译：辐射源
公开(公告)号：WO2013029906A1
公开(公告)日：2013-03-07
申请号：PCT/EP2012/065037
申请日：2012-08-01
申请人： ASML NETHERLANDS B.V. , YAKUNIN, Andrei , IVANOV, Vladimir , VAN SCHOOT, Jan , KRIVTSUN, Vladimir , SWINKELS, Gerardus , MEDVEDEV, Viacheslav
发明人： YAKUNIN, Andrei , IVANOV, Vladimir , VAN SCHOOT, Jan , KRIVTSUN, Vladimir , SWINKELS, Gerardus , MEDVEDEV, Viacheslav
IPC分类号： H05G2/00 , G03F7/20
CPC分类号： G03F7/70033 , H05G2/005 , H05G2/006 , H05G2/008
摘要： A radiation source (60) suitable for providing a beam of radiation to an illuminator of a lithographic apparatus. The radiation source comprises a nozzle configured to direct a stream of fuel droplets (62) along a trajectory (64) towards a plasma formation location (66). The radiation source is configured to receive a first amount of radiation (68) such that the first amount of radiation is incident on a fuel droplet (62a) at the plasma formation location, and such that the first amount of radiation transfers energy into the fuel droplet to generate a modified fuel distribution (70), the modified fuel distribution having a surface. The radiation source is also configured to receive a second amount of radiation (72) such that the second amount of radiation is incident on a portion of the surface (70a) of the modified fuel distribution, the second amount of radiation having a p-polarized component with respect to the portion of the surface; and such that the second amount of radiation transfers energy to the modified fuel distribution to generate a radiation generating plasma, the radiation generating plasma emitting a third amount of radiation (74). The radiation source further comprises a collector (CO) configured to collect and direct at least a portion of the third amount of radiation. The radiation source is configured such that the second amount of radiation propagates in a first direction, the first direction being non-parallel to a normal to the portion of the surface of the modified fuel distribution.
摘要翻译：适于向光刻设备的照明器提供辐射束的辐射源（60）。辐射源包括被配置为沿着轨迹（64）将燃料液滴（62）流引向等离子体形成位置（66）的喷嘴。辐射源被配置为接收第一量的辐射（68），使得第一量的辐射入射在等离子体形成位置处的燃料液滴（62a）上，并且使得第一量的辐射将能量转移到燃料液滴以产生改进的燃料分配（70），所述改进的燃料分布具有表面。辐射源还被配置为接收第二数量的辐射（72），使得第二量的辐射入射在改性燃料分布的表面（70a）的一部分上，第二量的辐射具有p偏振相对于表面的部分; 并且使得第二量的辐射将能量传递到经修改的燃料分布以产生辐射产生等离子体，该辐射产生等离子体发射第三量的辐射（74）。辐射源还包括收集器（CO），其被配置成收集并引导第三量的辐射的至少一部分。辐射源被配置成使得第二数量的辐射在第一方向上传播，第一方向不平行于改性燃料分布的表面部分的法线。

7. 发明申请

WO2015034526A1 DEVICE, SYSTEM AND METHOD OF CONFIGURING A RADIO TRANSCEIVER 审中-公开
标题翻译：装置，系统和配置无线电收发器的方法
公开(公告)号：WO2015034526A1
公开(公告)日：2015-03-12
申请号：PCT/US2013/058654
申请日：2013-09-08
申请人： INTEL CORPORATION , IVANOV, Vladimir , MUECK, Markus Dominik , ALAVI, Hossein
发明人： IVANOV, Vladimir , MUECK, Markus Dominik , ALAVI, Hossein
IPC分类号： G06F9/44 , H04B1/00
CPC分类号： H04L41/0813 , G06F9/44505 , H04B1/40 , H04W88/06
摘要： Some demonstrative embodiments include devices, systems and/or methods of configuring a radio transceiver. For example, some embodiment include a radio virtual machine (RVM) to configure a radio transceiver, the RVM including a radio processor to execute a first code configuring one or more transceiver functionalities independent of a configuration of the radio transceiver, and to generate a second code based on the configuration of the radio transceiver and the first code, wherein the second code is to be executed by the radio transceiver to configure the one or more transceiver functionalities for the radio transceiver.
摘要翻译：一些演示实施例包括配置无线电收发机的设备，系统和/或方法。例如，一些实施例包括用于配置无线电收发器的无线电虚拟机（RVM），RVM包括无线电处理器以执行独立于无线电收发器的配置的一个或多个收发器功能的第一代码，并且产生第二个基于无线电收发器和第一代码的配置的代码，其中第二代码将由无线电收发器执行以配置无线电收发器的一个或多个收发机功能。

8. 发明申请

WO2013100783A1 METHOD AND SYSTEM FOR CONTROL SIGNALLING IN A DATA PATH MODULE 审中-公开
标题翻译：数据路径模块中控制信号的方法和系统
公开(公告)号：WO2013100783A1
公开(公告)日：2013-07-04
申请号：PCT/RU2011/001049
申请日：2011-12-29
申请人： INTEL CORPORATION , IVANOV, Vladimir
发明人： IVANOV, Vladimir
IPC分类号： G06F15/16
CPC分类号： G06F9/30032 , G06F9/32 , G06F9/3877 , G06F9/3897 , G06F13/4068 , G06F15/17
摘要： Techniques and mechanisms for exchanging control signals in a data path module of a data stream processing engine. In an embodiment, the data path module may be configured to form a set of one or more data paths corresponding to an instruction which is to be executed. In another embodiment, data processing units of the data path module may be configured to exchange one or more control signals for elastic execution of the instruction.
摘要翻译：用于在数据流处理引擎的数据路径模块中交换控制信号的技术和机制。在一个实施例中，数据路径模块可以被配置为形成与要执行的指令相对应的一个或多个数据路径的集合。在另一个实施例中，数据路径模块的数据处理单元可以被配置为交换一个或多个控制信号以用于指令的弹性执行。

9. 发明申请

WO2013100782A1 METHOD AND SYSTEM FOR CONTROLLING EXECUTION OF AN INSTRUCTION SEQUENCE IN A ACCELERATOR. 审中-公开
标题翻译：用于控制加速器中指令序列执行的方法和系统。
公开(公告)号：WO2013100782A1
公开(公告)日：2013-07-04
申请号：PCT/RU2011/001048
申请日：2011-12-29
申请人： INTEL CORPORATION , IVANOV, Vladimir
发明人： IVANOV, Vladimir
IPC分类号： G06F17/00
CPC分类号： G06F9/3885 , G06F9/3877 , G06F15/82
摘要： Techniques and mechanisms for controlling execution of an instruction sequence in a data stream processing engine. In an embodiment, a control unit of the data stream processing engine detects that execution of a first instruction in an instruction sequence has ended. In another embodiment, the control unit determines information regarding a next instruction of the instruction sequence which is to be executed. Control signals may be sent from the control unit to form a data path set for execution of the next instruction in the instruction sequence.
摘要翻译：用于控制数据流处理引擎中的指令序列的执行的技术和机制。在一个实施例中，数据流处理引擎的控制单元检测到指令序列中的第一指令的执行已经结束。在另一个实施例中，控制单元确定关于要被执行的指令序列的下一个指令的信息。可以从控制单元发送控制信号以形成用于在指令序列中执行下一条指令的数据路径。

10. 发明申请

WO2012126492A1 MANAGEMENT OF ICONS FOR DIGITAL MAPS 审中-公开
标题翻译：数字图像图形管理
公开(公告)号：WO2012126492A1
公开(公告)日：2012-09-27
申请号：PCT/EP2011/005437
申请日：2011-10-27
申请人： HARMAN BECKER AUTOMOTIVE SYSTEMS GMBH , SPINDLER, CC , IVANOV, Vladimir , FISCHER, Martin , SCHÜTZ, Simon
发明人： SPINDLER, CC , IVANOV, Vladimir , FISCHER, Martin , SCHÜTZ, Simon
IPC分类号： G01C21/32 , G06F17/30 , G01C21/36
CPC分类号： G01C21/00 , G01C21/32 , G01C21/3682 , G06F3/04817 , G06F17/30241 , G06F17/30244 , G06F17/30265 , G06F17/30268 , G06F17/3028 , G06F17/30324 , G09G5/39
摘要： The present invention relates to a method for the management of icons in a navigation database comprising storing data for a plurality of icons in one single data array representing an image containing the plurality of icons.
摘要翻译：本发明涉及一种用于管理导航数据库中的图标的方法，包括在表示包含多个图标的图像的单个数据阵列中存储多个图标的数据。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式